NCT04555564

Brief Summary

This is a single-arm, single-center, prospective pilot study to perform bronchial artery Tc-99m-MAA infusion to determine the predicted whole lung versus lung tumor dosimetry of a possible intra-arterial radioembolization.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 18, 2020

Completed
1.9 years until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

August 18, 2022

Status Verified

August 1, 2021

Enrollment Period

2.4 years

First QC Date

September 14, 2020

Last Update Submit

August 15, 2022

Conditions

Keywords

Lung cancerlung metastasisBronchial artery embolizationMAA studyDosimetry

Outcome Measures

Primary Outcomes (1)

  • Quantification of Tc99m-MAA uptake

    The primary objective will be quantification of Tc99m-MAA uptake (measured in "Gray") within the tumor and surrounding structures (esophagus, bronchi, pericardium, spine). This is a purely descriptive study and no statistical comparison or correlation will be made. This assessment will be done for each participant at 12 months.

    12 months

Study Arms (1)

Technicium 99 MAA

EXPERIMENTAL

Participants will receive bronchial artery administration of Technicium 99 MAA

Procedure: Technicium 99 MAA infusion

Interventions

4mci of Technicium 99 MAA will be infused into the bronchial artery via a catheter prior to a standard therapy (bronchial artery embolization). The patient will undergo nuclear medicine imaging following this intervention to quantify MAA distribution within the lung tumor and adjacent lung tissue.

Technicium 99 MAA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects 18 years of age and older
  • Patients with known active lung cancer with a history of prior hemoptysis presenting for bronchial artery embolization will be considered.
  • Patients must be presenting for secondary prophylaxis of hemoptysis
  • Willing and able to understand and sign a written informed consent document.
  • Willing and able to undergo all study procedures.

You may not qualify if:

  • Patients with current active hemoptysis
  • Any acute or chronic inflammatory disease or medical conditions that in the investigator's opinion may interfere with the study procedures or the interpretation of the study results.
  • If female, not of childbearing potential or negative serum β-human chorionic gonadotropin pregnancy test prior to radiotracer injection.
  • If female, not nursing.
  • History of allergic reactions attributed to compounds of similar chemical or biologic composition to macro-aggregated albumin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Chun JY, Belli AM. Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysis. Eur Radiol. 2010 Mar;20(3):558-65. doi: 10.1007/s00330-009-1591-3. Epub 2009 Sep 2.

    PMID: 19727742BACKGROUND
  • Wang GR, Ensor JE, Gupta S, Hicks ME, Tam AL. Bronchial artery embolization for the management of hemoptysis in oncology patients: utility and prognostic factors. J Vasc Interv Radiol. 2009 Jun;20(6):722-9. doi: 10.1016/j.jvir.2009.02.016. Epub 2009 May 5.

    PMID: 19406667BACKGROUND
  • Swanson KL, Johnson CM, Prakash UB, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization : experience with 54 patients. Chest. 2002 Mar;121(3):789-95. doi: 10.1378/chest.121.3.789.

    PMID: 11888961BACKGROUND
  • Eldridge L, Moldobaeva A, Zhong Q, Jenkins J, Snyder M, Brown RH, Mitzner W, Wagner EM. Bronchial Artery Angiogenesis Drives Lung Tumor Growth. Cancer Res. 2016 Oct 15;76(20):5962-5969. doi: 10.1158/0008-5472.CAN-16-1131. Epub 2016 Aug 28.

    PMID: 27569207BACKGROUND
  • Jonas AM, Carrington CB. Vascular patterns in primary and secondary pulmonary tumors in the dog. Am J Pathol. 1969 Jul;56(1):79-95. No abstract available.

    PMID: 4893319BACKGROUND
  • CUDKOWICZ L, ARMSTRONG JB. The blood supply of malignant pulmonary neoplasms. Thorax. 1953 Jun;8(2):153-6. doi: 10.1136/thx.8.2.152. No abstract available.

    PMID: 13077512BACKGROUND
  • Ricke J, Grosser O, Amthauer H. Y90-radioembolization of lung metastases via the bronchial artery: a report of 2 cases. Cardiovasc Intervent Radiol. 2013 Dec;36(6):1664-1669. doi: 10.1007/s00270-013-0690-3. Epub 2013 Jul 10.

    PMID: 23839007BACKGROUND

MeSH Terms

Conditions

HemoptysisNeoplasmsLung Neoplasms

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and SymptomsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by Site

Study Officials

  • Ji Buethe, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Single arm, prospective, single-center
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2020

First Posted

September 18, 2020

Study Start

August 1, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

August 18, 2022

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share